Condensed Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash Flows from Operating Activities
Net loss	$ (19,708,975)	$ (19,424,558)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	839,794	691,191
Amortization of right-of-use assets	(105,534)	(113,419)
Inventory reserve	57,350	20,277
Stock-based compensation	503,930	624,769
Warrant inducement expense	2,102,109	1,831,116
Gain on disposal of fixed assets	(1,680)
Increase/(decrease) in cash resulting from changes in:
Accounts receivable, net	(4,427,547)	(1,287,334)
Inventory	(2,605,153)	(120,241)
Prepaid expenses and other current assets	165,353	322,299
Accounts payable	3,853,736	(198,400)
Accrued liabilities	642,516	76,932
Net cash used in operating activities	(18,684,101)	(17,577,368)
Cash Flows from Investing Activities:
Purchases of fixed assets	(64,331)	(297,877)
Net cash used in investing activities	(64,331)	(297,877)
Cash Flows from Financing Activities:
Net proceeds from issuance of common stock and warrants	24,193,930	16,779,772
Proceeds from exercise of common stock warrants	2,401,704	2,513,172
Proceeds from warrant exercise inducement, net		2,337,298
Proceeds from exercise of overallotment warrants	659,958
Payments on finance leases	(518,190)	(378,389)
Payments on supplier and other third-party financings	(432,435)	(260,537)
Net cash provided by financing activities	26,304,967	20,991,316
Net increase in Cash	7,556,535	3,116,071
Cash at Beginning of Period	9,301,406	3,423,373
Cash at End of Period	16,857,941	6,539,444
Cash paid during the period for:
Interest	$ 171,891	$ 187,574